Article
Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis.
Circulation journal : official journal of the Japanese Circulation Society - 25 Jun 2020
Mori Hiroyoshi, Ishibashi Tomohiko, Inagaki Tadakatsu, Okazawa Makoto, Masaki Takeshi, Asano Ryotaro, Manabe Yusuke, Ohta-Ogo Keiko, Narazaki Masashi, Ishibashi-Ueda Hatsue, Kumanogoh Atsushi, Nakaoka Yoshikazu
Abstract excerpt
BACKGROUND: Pulmonary arterial hypertension (PAH), particularly connective tissue disease-associated PAH (CTD-PAH), is a progressive disease and novel therapeutic agents based on the specific molecular pathogenesis are desired. In the pathogenesis of CTD-PAH, inflammation, immune cell abnormality, and fibrosis play important roles. However, the existing mouse pulmonary hypertension (PH) models do not reflect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
